Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
HNI $2.2 billion acquisition of Steelcase
We are advising HNI on the transaction
BDT & MSD Partners acquisition of Summit Companies
We advised BDT & MSD Partners on the transaction
Credit facilities and preferred equity financing amendments for a software company
We advised the agent, lender and investor on the transaction
Amneal Pharmaceuticals $600 million notes offering
We advised Amneal Pharmaceuticals on its high-yield notes offering
NCB Financial Group $225 million senior secured notes offering
The high-yield notes are due 2030
Ambiq Micro $110.4 million IPO
The shares are listed on the New York Stock Exchange
Cricket Valley Energy Center equitization and comprehensive recapitalization
We advised the mezzanine lender and administrative agent on the transaction
Synchrony Financial $1 billion senior notes offering
The investment-grade notes are due 2029 and 2036
Mavenir Systems comprehensive out-of-court debt recapitalization
We advised an ad hoc group of term loan lenders on the transaction
Macy’s $500 million senior notes offering and $250 million tender offers
The high-yield notes are due 2033